Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Validation of the Czech Montreal Cognitive Assessment for Mild Cognitive Impairment due to Alzheimer Disease and Czech Norms in 1,552 Elderly Persons

A. Bartos, D. Fayette,

. 2018 ; 46 (5-6) : 335-345. [pub] 20181204

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't, Validation Study

BACKGROUND: The Czech version of the Montreal Cognitive Assessment (MoCA-CZ) and delayed recall of 5 words have not been validated in patients with mild cognitive impairment (MCI) due to Alzheimer disease (AD) and compared to norms of a large population. METHOD: The MoCA-CZ was administered to 1,600 elderly individuals in 2 groups consisting of 48 patients with MCI due to AD (AD-MCI) and 1,552 normal elderly adults. RESULTS: MoCA-CZ scores were significantly lower in the AD-MCI patients than in the normal elderly (21 ± 4 vs. 26 ± 3 points; p = 0.03). Under the recommended cutoff score of ≤25, the MoCA-CZ demonstrated an excellent sensitivity of 94% but a low specificity of 62%. When the score was reduced to ≤24, the MoCA-CZ showed an optimal sensitivity of 87% for AD-MCI and a specificity of 72%. Normal elderly persons should recall at least 2 words after delay (sensitivity 80%, specificity 74%). Several cutoff points were derived from normative data stratified by age and education. CONCLUSIONS: The cutoff for AD-MCI and stratified norms are available for the MoCA total score and delayed recall of the Czech version. The cut-off scores of the MoCA-CZ, sensitivity, and specificity are lower than in the original study.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028025
003      
CZ-PrNML
005      
20240807140020.0
007      
ta
008      
190813s2018 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000494489 $2 doi
035    __
$a (PubMed)30513529
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bartos, Ales $u National Institute of Mental Health, Klecany, Czech Republic, ales.bartos@nudz.cz. AD Center, Department of Neurology, University Hospital Královské Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic, ales.bartos@nudz.cz.
245    10
$a Validation of the Czech Montreal Cognitive Assessment for Mild Cognitive Impairment due to Alzheimer Disease and Czech Norms in 1,552 Elderly Persons / $c A. Bartos, D. Fayette,
520    9_
$a BACKGROUND: The Czech version of the Montreal Cognitive Assessment (MoCA-CZ) and delayed recall of 5 words have not been validated in patients with mild cognitive impairment (MCI) due to Alzheimer disease (AD) and compared to norms of a large population. METHOD: The MoCA-CZ was administered to 1,600 elderly individuals in 2 groups consisting of 48 patients with MCI due to AD (AD-MCI) and 1,552 normal elderly adults. RESULTS: MoCA-CZ scores were significantly lower in the AD-MCI patients than in the normal elderly (21 ± 4 vs. 26 ± 3 points; p = 0.03). Under the recommended cutoff score of ≤25, the MoCA-CZ demonstrated an excellent sensitivity of 94% but a low specificity of 62%. When the score was reduced to ≤24, the MoCA-CZ showed an optimal sensitivity of 87% for AD-MCI and a specificity of 72%. Normal elderly persons should recall at least 2 words after delay (sensitivity 80%, specificity 74%). Several cutoff points were derived from normative data stratified by age and education. CONCLUSIONS: The cutoff for AD-MCI and stratified norms are available for the MoCA total score and delayed recall of the Czech version. The cut-off scores of the MoCA-CZ, sensitivity, and specificity are lower than in the original study.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a Alzheimerova nemoc $x komplikace $x psychologie $7 D000544
650    12
$a kognitivní dysfunkce $x diagnóza $x etiologie $7 D060825
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a rozpomínání $7 D011939
650    12
$a testy pro posouzení mentálních funkcí a demence $7 D000073216
650    _2
$a neuropsychologické testy $7 D009483
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a sebepojetí $7 D012649
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a překládání $7 D014175
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a validační studie $7 D023361
700    1_
$a Fayette, Dan, $u National Institute of Mental Health, Klecany, Czech Republic. $d 1981- $7 xx0321144
773    0_
$w MED00006046 $t Dementia and geriatric cognitive disorders $x 1421-9824 $g Roč. 46, č. 5-6 (2018), s. 335-345
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30513529 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20240807140015 $b ABA008
999    __
$a ok $b bmc $g 1433174 $s 1066485
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 46 $c 5-6 $d 335-345 $e 20181204 $i 1421-9824 $m Dementia and geriatric cognitive disorders $n Dement Geriatr Cogn Disord $x MED00006046
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...